Takeda Pharmaceutical Co Ltd
NYSE:TAK

Watchlist Manager
Takeda Pharmaceutical Co Ltd Logo
Takeda Pharmaceutical Co Ltd
NYSE:TAK
Watchlist
Price: 14.88 USD -1.26% Market Closed
Market Cap: 47.2B USD

Intrinsic Value

The intrinsic value of one TAK stock under the Base Case scenario is 17.88 USD. Compared to the current market price of 14.88 USD, Takeda Pharmaceutical Co Ltd is Undervalued by 17%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

TAK Intrinsic Value
17.88 USD
Undervaluation 17%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Takeda Pharmaceutical Co Ltd

What is Valuation History?
Compare TAK to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Takeda Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Takeda Pharmaceutical Co Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Takeda Pharmaceutical Co Ltd

Current Assets 2.5T
Cash & Short-Term Investments 405.6B
Receivables 725.3B
Other Current Assets 1.4T
Non-Current Assets 11.7T
Long-Term Investments 361.9B
PP&E 2T
Intangibles 9T
Other Non-Current Assets 441B
Efficiency

Free Cash Flow Analysis
Takeda Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Takeda Pharmaceutical Co Ltd

Revenue
4.6T JPY
Cost of Revenue
-1.6T JPY
Gross Profit
3T JPY
Operating Expenses
-2.7T JPY
Operating Income
342.6B JPY
Other Expenses
-234.7B JPY
Net Income
107.9B JPY
Fundamental Scores

TAK Profitability Score
Profitability Due Diligence

Takeda Pharmaceutical Co Ltd's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Sustainable 3Y Average Operating Margin
Declining Gross Margin
46/100
Profitability
Score

Takeda Pharmaceutical Co Ltd's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

TAK Solvency Score
Solvency Due Diligence

Takeda Pharmaceutical Co Ltd's solvency score is 35/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Positive Net Debt
35/100
Solvency
Score

Takeda Pharmaceutical Co Ltd's solvency score is 35/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TAK Price Targets Summary
Takeda Pharmaceutical Co Ltd

Wall Street analysts forecast TAK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TAK is 17.32 USD with a low forecast of 15.36 USD and a high forecast of 20.94 USD.

Lowest
Price Target
15.36 USD
3% Upside
Average
Price Target
17.32 USD
16% Upside
Highest
Price Target
20.94 USD
41% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Takeda Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

TAK News

Other Videos
What is the Intrinsic Value of one TAK stock?

The intrinsic value of one TAK stock under the Base Case scenario is 17.88 USD.

Is TAK stock undervalued or overvalued?

Compared to the current market price of 14.88 USD, Takeda Pharmaceutical Co Ltd is Undervalued by 17%.

Back to Top